Goldman Sachs
HCAT icon

Goldman Sachs’s Health Catalyst HCAT Stock Holding History

Goldman Sachs’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-37,200
Closed -$1.36M – 5571
2020
Q3 		$1.36M Hold
37,200
– – ﹤0.01% 3857
2020
Q2 		$1.08M Hold
37,200
– – ﹤0.01% 3891
2020
Q1 		$973K Buy
+37,200
New +$1.14M ﹤0.01% 3784

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs's HCAT Position: Q1 2026 in Review

Goldman Sachs increased its Health Catalyst (HCAT) stake by 22% in Q1 2026, buying an estimated $132K and bringing the position to 387,172 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #5609.

Goldman Sachs first reported a position in HCAT in Q3 2019 and has held it in 26 quarters since. The position peaked at $20.7M in Q2 2022. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Goldman Sachs held 387,172 shares of Health Catalyst worth $492K as of Q1 2026.
  • Goldman Sachs bought 70,370 Health Catalyst shares in Q1 2026, an estimated $132K.
  • Health Catalyst made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5609 holding.
  • Goldman Sachs first reported a position in Health Catalyst in Q3 2019 and has held it in 26 quarters since.
  • Goldman Sachs's Health Catalyst position peaked at $20.7M in Q2 2022.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.